Research at Fox Chase

Find a Clinical Trial

By The Numbers

A Century of Excellence

National rankings, accreditations, awards. The numbers are in your favor.
Read more »

The Best Doctors Supported by the Best Team

Your Healthcare Team

Our unique staff of health-care professionals focus solely on oncology. Your team is here.
Read more »

The Scientist Rates Fox Chase a Best Place to Work in Academia

Top Ten Best Places to Work Academia 2013
Read more »

Center for Research

A unique and intense set of collaborations, even for a cancer center: cross-disciplinary efforts in which ideas, inspiration, and insight flow from lab bench to bedside and back again.

New technologies and cancer treatments often are available at Fox Chase before becoming standard practice in the community.

Whether it's a clinical trial of a new chemotherapy, a new technology, or a new surgical procedure, our treatments are based on years of research. 

Research done here at Fox Chase. 

At Fox Chase, research takes place with an unusually high degree of interaction between our basic researchers and our doctors. For this reason, we're able to bring laboratory discoveries to the forefront of patient care.

Combine this pioneering research with experienced physicians and advanced surgical, radiation, and diagnostic technology, and patients have the full resources of a National Cancer Institute Designated Comprehensive Cancer Center.

We have a variety of clinical trials, bringing tomorrow's treatments here now.

Combining research in many disciplines with patient care enables Fox Chase to translate new research findings into medical applications that may become models for improved cancer care.

At any one time, about 170 clinical trials of new prevention, diagnostic and treatment techniques are under way. Fox Chase is also involved in developing trials to test new drugs that may prevent cancer in high-risk individuals.
Find a Clinical Trial

Phase I clinical trials

Fox Chase has a special clinical-studies wing that includes a 10-bed special-care unit for patients participating in Phase I clinical trials. This unique unit is dedicated to clinical research for new cancer treatments such as developmental chemotherapy and studies of drug resistance.